| Oelsner, Sarah (Scitaris 202204 Managing Partner) |
Managing Partner |
Scitaris (Group) |
Germany |
| Oesch, Bruno (Neurotune 200903– CEO before co-founder + Board Chairman) |
Chief Executive Officer (CEO) |
Neurotune AG |
Switzerland |
| Oeser, Rahel (Singleron 202409 PR Manager at Singleron Biotechnologies GmbH) |
Public Relations Manager / Investor Relations Manager |
Singleron (Group) |
Germany |
| Oestreich, Stephanie (Mnemo Therapeutics 202106 VP of Operations + Head of Alliance Management) |
Chief Operating Officer (COO) |
Mnemo Therapeutics (FR) |
France |
| Oetker, Roland (ROI Verwaltungsgesellschaft mbH 200108 Managing Director + Founder) |
Managing Director |
ROI Verwaltungsgesellschaft mbH (Roland Oetker) |
Germany |
| Offerhaus, Mark (Micreos 201602 CEO) |
Chief Executive Officer (CEO) |
Micreos (Group) |
Netherlands |
| Ofner, Alessandro (Microcaps 202101 Co-CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Microcaps AG |
Switzerland |
| Ogunshola, Lara (Lipidon 201808 Chief Marketing Officer) |
Sales Manager / Marketing Manager |
Lipidon AG (Lipidon Analytics) |
Switzerland |
| Oh, Daesuk (Miltenyi Biotec 201306– General Manager of Miltenyi Biotec Korea) |
General Manager (management) |
Miltenyi Biotec (Group) |
Korea, Republic of |
| Ohtani, Masahiko (Evotec 201307– VP Business Development Japan) |
Business Development Manager / Strategy Manager |
Evotec (Group) |
Germany |
| Ohtsuki, Atsushi (Nanion 201501 General Manager Nanion Japan) |
General Manager (management) |
Nanion Technologies Research Lab Tokyo (at TWIns) |
Japan |
| Oinonen, Tero (4Pharma 202306 CEO) |
Chief Executive Officer (CEO) |
BC Platforms (BCP) (Group) |
Finland |
| Okimoto, Yuko (PeptiDream 202404 IR + Public Affairs) |
Public Relations Manager / Investor Relations Manager |
PeptiDream Inc. (JP) |
Japan |
| Okrongly, David (Opko Health 201307– President Diagnostics unit before Quanterix + Siemens Healthcare) |
Chief Executive Officer (CEO) |
Opko Health (Group) |
United States (USA) |
| Olczak, Jacek (Philip Morris 202107 CEO) |
Chief Executive Officer (CEO) |
Philip Morris (Group) |
United States (USA) |
| Oldekor, Herr |
n. a. |
Deutsche Bank (Group) |
Germany |
| Oldham, Steve (Carbon Engineering 202109 CEO) |
Chief Executive Officer (CEO) |
Carbon Engineering |
|
| Olek, Alexander (Epigenomics 200508) |
n. a. |
Epigenomics (Group) |
Germany |
| Olek, Sven (Epiontis 2003– Co-Founder) |
Managing Director |
Precision Medicine Group (Group) |
Germany |
| Olfers, Frank (Breatec 202202 Managing Director) |
Managing Director |
BRAIN Biotech (Group) |
Netherlands |
| Olgemöller, Bernhard (Labor Becker Olgemöller 200909 Head) |
President/Director/Head Business Group/Unit/Division |
Labor Becker, Olgemöller & Kollegen |
Germany |
| Oliverio, Joseph (ITM Isotope Technologies Munich 202501– CEO of Actineer before Ionetix + Imagin Molecular + Positron) |
Chief Executive Officer (CEO) |
ITM Isotope Technologies Munich SE |
Canada |
| Oliveto, Joseph (Milestone Pharmaceuticals 201703– CEO before Chelsea Therapeutics + Galleon + Pappas Ventures) |
Chief Executive Officer (CEO) |
Milestone Pharmaceuticals (Group) |
Canada |
| Ollier, Michèle (Medixci Ventures 201602– General Partner before Index Ventures + Funxional Therapeutics) |
General Partner (venture partner) |
Medicxi Ventures (formerly Index Ventures Life Sciences) |
United Kingdom (GB) |
| Olmes, Andreas (High-Tech Gründerfonds 200901 Investment Manager) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Olschewski, Torsten (Analytik Jena 200811 VP Sales + Service + Marketing) |
Sales Manager / Marketing Manager |
Endress+Hauser (Group) |
Germany |
| Olsen, Jesper Velgaard (Univ Copenhagen 201404– Professor + Vice Director of NNF-CPR joined 5/09 before MPI) |
Professor |
Max Planck Society for the Advancement of Science |
Germany |
| Olvany, Sophie (Nemis Technologies 202202 Business Development Executive) |
Business Development Manager / Strategy Manager |
Nemis Technologies AG |
Switzerland |
| Omari, Abdelghani (Paion 201409– CFO joined 200810 as VP Finance before KPMG Cologne) |
Chief Financial Officer (CFO) |
Humanwell Healthcare (Group) |
Germany |
| Onakunle, Yemi (JSR Corp 202001– promoted to CBO of Selexis joined 2012 before Diosynth RTP Inc + Lonza) |
Chief Business Officer (CBO) |
JSR Corporation (Group) |
Switzerland |
| Ondish, Mary Ann (ADC Therapeutics 202206 Media Relations) |
Public Relations Manager / Investor Relations Manager |
ADC Therapeutics (Group) |
Switzerland |
| Ong, Siew Hwa (Acumen Research Laboratories 201510 CEO + Adjunct Prof at NUS) |
Chief Executive Officer (CEO) |
Acumen Research Laboratories Pte Ltd. |
Singapore |
| Onsi, Douglas E. (HealthCare Ventures 201601 Managing Director + Tensha Therapeutics 201601 CEO) |
Managing Director |
HealthCare Ventures (Group) |
United States (USA) |
| Onuscheck, Michael (Novartis 201810 President Global Business + Innovation at Alcon) |
Business Development Manager / Strategy Manager |
Novartis (Group) |
Switzerland |
| Oostvogels, Lidia (CureVac 202102 VP Area Head Infectious Diseases) |
President/Director/Head Business Group/Unit/Division |
CureVac (Group) |
Germany |
| Opalko-Berry, Alison (Trophic Communications 202405) |
Public Relations Manager / Investor Relations Manager |
Trophic Communications GmbH |
Germany |
| Opella, Stanley (Univ California 201312 Prof of Chemistry + Biochemistry at UCSD) |
Professor |
University of California (System) |
United States (USA) |
| Oppitz, Norbert (Swedish Orphan Biovitrum 201710– SVP Specialty Care before BSN Medical + Endo + Takeda/Nycomed + Roche) |
President/Director/Head Business Group/Unit/Division |
Swedish Orphan Biovitrum (Sobi) (Group) |
Sweden |
| Opstelten, Ron (Greiner 201511 Managing Director at Greiner Bio-One Diagnostics GmbH before Operon Biotechnologies GmbH) |
Managing Director |
Greiner (Group) |
Austria |
| Orbán, Gábor (Gedeon Richter 202401 CEO) |
Chief Executive Officer (CEO) |
Gedeon Richter (Group) |
Hungary |
| Oredsson, Michael (BioInvent 201310 CEO before CEO at Probi AB before Pharmacia) |
Chief Executive Officer (CEO) |
BioInvent International AB (Nasdaq Stockholm: BINV) |
Sweden |
| Oren, Dan (Dexcel 1068– CEO + Founder) |
Chief Executive Officer (CEO) |
Dexcel Pharma (Group) |
Israel |
| Orloff, John (Alexion 2010706– EVP Head RnD before Novelion + Baxalta + Baxter + Merck Serono) |
Research & Development Manager |
AstraZeneca (Group) |
United States (USA) |
| Orlova, Anna (Riana Therapeutics 202411 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
RIana Therapeutics GmbH |
Austria |
| Orlowski, Jochen (MorphoSys 201512– Corp Communications + IR Relations before 4SC AG + Süd-Chemie) |
Public Relations Manager / Investor Relations Manager |
Novartis (Group) |
Germany |
| Orlowski, Marek (Joint Polish Investment Fund 201503 General Partner before Co-founder of Nepentes SA) |
General Partner (venture partner) |
Joint Polish Investment Fund (JPIF) (Group) |
Netherlands |
| Ornell, John (Bruker 201508– Board Director before Waters 2001–2013 CFO RETIRED 2014) |
Board member, non-executive |
Bruker (Group) |
United States (USA) |
| Oroszlan, Peter (Zeptosens 200404 Director Business Development) |
Business Development Manager / Strategy Manager |
Bayer (Group) |
Switzerland |
| Orpin, Tristan (Cradle Genomics 202003 CEO before Illumina 201406 SVP + General Manager Reproductive + Genetic Health) |
Chief Executive Officer (CEO) |
Cradle Genomics (US) |
United States (USA) |
| Orquera, Christian |
n. a. |
Bankgesellschaft Berlin (Group) |
Germany |
| Orth, Gisela (Qiagen 200902– VP Global Human Resources before Continental) |
Human Resources Manager |
Qiagen (Group) |
Germany |
| Ortin, Philip (Traceless Materials 202309 Head of Marketing + Sales) |
Sales Manager / Marketing Manager |
Traceless Materials GmbH |
Germany |
| Ortiz, Sara (Trophic Communications 202408) |
Public Relations Manager / Investor Relations Manager |
Trophic Communications GmbH |
Germany |
| Ortner, Iris (IGO Industries 202410 CEO of IGO Innovation GmbH) |
Chief Executive Officer (CEO) |
IGO Industries (Group) |
Austria |
| Orwin, John (Atreca 201901 CEO before Genentech + Tibotec) |
Chief Executive Officer (CEO) |
Atreca Inc. (Nasdaq: BCEL) |
United States (USA) |
| Orzelek, Ben (ITM 202111– Head of Investor Relations befoore Sartorius) |
Public Relations Manager / Investor Relations Manager |
ITM (Group) |
Germany |
| Osborne, Lisa (Rana Healthcare Solutions LLC 201311 CEO + Founder before Waggener Edstrom Worldwide) |
Public Relations Manager / Investor Relations Manager |
Rana Healthcare Solutions LLC |
United States (USA) |
| Oschmann, Stefan (Merck (DE) 201604– CEO before Executive Board Member since 2011 before MSD) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
Germany |
| Osherovich, Lev (Delin Ventures 202210 Partner) |
Partner (venture partner) |
Delin Ventures (GB) |
United Kingdom (GB) |
| Ossenbühl, Anne (High-Tech Gründerfonds 202108– CFO before Duales System Holding GmbH) |
Chief Financial Officer (CFO) |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Ossipow, Vincent (Omega Funds 202004) |
Partner (venture partner) |
Omega Funds (Group) |
United States (USA) |
| Ossmann, Christian (MKS Instruments 2012– Sales Manager Continental Europe) |
Sales Manager / Marketing Manager |
MKS Instruments (Group) |
Germany |
| Osswald, Ulrich (Lonza 202306 VP Licensing) |
IP Manager |
Lonza (Group) |
Switzerland |
| Oster, Wolfgang |
n. a. |
PolyTechnos Funds |
Germany |
| Osterholz, Daniela (Centogene 202002 Head of Human Resources) |
Human Resources Manager |
Centogene (Group) |
Germany |
| Ostermeier, Max G. (Implandata Ophtalmic Products GmbH 201201 Managing Director + Co-founder) |
Managing Director |
Implandata Ophthalmic Products GmbH (IOP) |
Germany |
| Osterwald, Hermann (NextPharma 201010 Managing Director NextPharma GmbH) |
Managing Director |
NextPharma (Group) |
Germany |
| Osterwalder, Bruno (Roche + Merck Serono) |
n. a. |
Roche (Group) |
Switzerland |
| Osthus, Torsten (Osthus 201508 Managing Director + Founder) |
Sales Manager / Marketing Manager |
Osthus (Group) |
Germany |
| Ostrout, Nicholas (Lonza 202112 Senior Director Business Strategy + Implementation Personal Medicine) |
Business Development Manager / Strategy Manager |
Lonza (Group) |
Switzerland |
| Ostuni, Emanuele (ArtBio 202401 CEO + Co-Founder) |
n. a. |
ArtBio (Group) |
United States (USA) |
| Oswald, Andrin (Somagenetix 202410– CEO before Centogene + Gates Foundation + GSK + Novartis + McKinsey) |
Chief Executive Officer (CEO) |
Centogene (Group) |
Germany |
| Otsuka, Hiromasa (Sony 201206 SVP + Head Life Sciences Business at Sony Medical Business Unit) |
President/Director/Head Business Group/Unit/Division |
Sony Medical Business Unit (Sony MBU) |
|
| Ott, Sabine (Sirion Biotech 201604– VP Licensing + BusDev before GeneWake + MWG Biotech) |
Business Development Manager / Strategy Manager |
PerkinElmer (Group) |
Germany |
| Ott, Victoria (Piabo PR 202305) |
Public Relations Manager / Investor Relations Manager |
Piabo PR GmbH |
Germany |
| Otte, Marcus (Oridis Biomarkers 201107 COO) |
Chief Operating Officer (COO) |
Oridis Biomarkers GmbH |
Austria |
| Ottenberg, Karsten (AATec Medical 202307 Board Chair + Co-Founder) |
Board member, non-executive |
AATec Medical GmbH |
Germany |
| Otto, Bernd |
n. a. |
Fraunhofer (Group) |
Germany |
| Otto, Janko |
n. a. |
Schott (Group) |
Germany |
| Otto, Michael (Otto Group 201502) |
n. a. |
|
|
| Otto, Mike (MVZ Trier + MPT Trier 201610 Founder + Owner) |
Company Founder |
MVZ für Histologie, Zytologie und Molekulare Diagnostik Trier (Dr. Kriegsmann + Dr. Otto) |
Germany |
| Otto, Ralf (Rentschler 201802– COO before McKinsey + Boehringer Ingelheim + Henkel) |
Chief Operating Officer (COO) |
Rentschler (Group) |
Germany |
| Oudova, Veronika (S-Biomedic 201807 CEO) |
Chief Executive Officer (CEO) |
Beiersdorf (Group) |
Belgium |
| Ounzain, Samir (Haya Therapeutics 202105 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Haya Therapeutics S.A. |
Switzerland |
| Ovaskainen, Jari |
n. a. |
Preon Capital (family office of Jari Ovaskainen) |
Switzerland |
| Overesch, Erich (OHB-System 200902 Head of Supervisory Board) |
Board member, non-executive |
Fuchs (Group) |
Germany |
| Overstijns, Toon (Miltenyi Biotec 202402 Managing Director of Miltenyi Biomedicine) |
Managing Director |
Miltenyi Biotec (Group) |
Germany |
| Ovodov, Sergej (BioGenes GmbH 201511 Managing Partner + Co-Founder) |
Managing Director |
BioGenes Gesellschaft für Biopolymere mbH (BioGenes GmbH) |
Germany |
| Owa, Takashi (Eisai 201910 VP Chief Medicine Creation + Chief Discovery Officer) |
n. a. |
Eisai (Group) |
Japan |
| Oyler, John V. (BeiGene 201305 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
BeOne Medicines (Group) (formerly BeiGene) |
China |
| O’Brien, Christine (Tizona Therapeutics 201804 VP Program Management) |
n. a. |
Tizona Therapeutics Inc. |
|
| O’Brien, James (Danaher 202408 VP Life Science + Applied Solutions at Leica Microsystems former Tecan) |
Technical Manager_oo |
Danaher (Group) |
Germany |
| O’Brien, Ron (Thermo Fisher 201003 Director Public Relations) |
Public Relations Manager / Investor Relations Manager |
Thermo Fisher (Group) |
United States (USA) |
| O’Bryan-Tear, Gillies (Algeta 201112 CMO) |
Chief Medical Officer (CMO) |
Bayer (Group) |
Norway |
| O’Callaghan, Brian (Petra Pharma 201804 CEO) |
Chief Executive Officer (CEO) |
Petra Pharma Corporation |
United States (USA) |
| O’Connell, Alan (Seroba Life Sciences 201702 Partner joined 2003 before Elan Corp + American Biogenetic Sciences) |
Partner (venture partner) |
Seroba (Group) |
Ireland, Republic of |
| O’Connell, Christopher J. (Chris) (Waters 201509–202009 CEO before over 21 years at Medtronic) |
Chief Executive Officer (CEO) |
Waters (Group) |
United States (USA) |
| O’Connor, Chris (Techcomp 201309 CEO of Techcomp Europe before Barloworld Scientific CEO) |
Chief Executive Officer (CEO) |
Techcomp (Group) |
United Kingdom (GB) |
| O’Day, Daniel (Gilead 201903– CEO before Roche Pharma CEO + COO + Roche Diagnostics COO joined Roche 1987) |
Chief Executive Officer (CEO) |
Gilead Sciences (Group) |
United States (USA) |
| O’Dowd, Hugh (Neon Therapeutics 20201 CEO) |
Chief Executive Officer (CEO) |
BioNTech (Group) |
United States (USA) |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 60 61 62 ... 94 95 96 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
